Subscribe To
Why shares of harmony bioscience are falling on friday
Harmony has already gotten approval for the drug to treat adults with excessive daytime sleepiness who ...
October 13, 2023, 12:52 pm
U.s. fda approves pfizer's inflammatory bowel disease drug
Pfizer said on Friday that theU.S. Food and Drug Administration has approved its drug to treat adults w...
October 13, 2023, 9:09 am
Why us online investors are trading less but earning more
A recent report by Investment Trends reveals a decline in online investor activity in the United States for the second consecutive year. The 2023 US O...
October 10, 2023, 8:28 am
Alnylam to scrap snda for patisiran after receiving fda complete response letter
Alnylam Pharmaceuticals Inc. ALNY, -1.00% said Monday it would no longer pursue its supplemental new drug application (sNDA) for patisiran as a treatm...
October 9, 2023, 7:43 am
Customer demographics are changing for penn entertainment: 1 big reason investors should take note
Penn Entertainment is a large casino operator. The historical image associated with casinos, with older adults...
October 6, 2023, 5:59 am
Moderna reportedly files submission for rsv vaccine with health canada
Moderna Therapeutics Inc (NASDAQ:MRNA) has filed a new drug submission for its vaccine aimed at preventing respiratory syncytial virus (RSV) in ...
October 5, 2023, 11:41 am
Moderna reports positive results for combination flu and covid vaccine
Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday, and said it w...
October 4, 2023, 8:09 am
The "adults in the room" are clueless. so maybe china is behind the rise in us long rates.
The relentless plunge in US Treasuries has left a trail of bewildered investors and analysts in its wake. Bond markets are often said to be the '...
October 4, 2023, 12:13 am
Fda accepts merck's (mrk) filing for sotatercept in pah disease
The FDA grants priority review to Merck's (MRK) FDA filing for sotatercept to treat adults with pulmona...
October 2, 2023, 12:46 pm
Build-a-bear workshop: financial fortitude, priced at 6x operating profits
Build-A-Bear Workshop, Inc.'s unique value proposition builds strong emotional connections with customers through its brand and stuffed animals. The c...
September 25, 2023, 1:48 pm
Fda expands lilly (lly) jardiance label in chronic kidney disease
Following the latest approval, Lilly's (LLY) Jardiance can access a target market that affects more than 35 million ...
September 25, 2023, 1:32 pm
Eli lilly, boehringer ingelheim's jardiance gets fda approval for chronic kidney disease
Eli Lilly & Co. LLY, -3.42% and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their blockbuster drug Jardia...
September 22, 2023, 8:49 am
Barbies to top christmas bestsellers thanks to nostalgia
Barbie's return to the limelight this year may just well see the dolls top this year's bestselling toys, according to Regent Street retailer Hamleys....
September 21, 2023, 11:01 am
Dollar demonstrates resilience once again
Here's a riddle for adults: countries stop using it, analysts predict its decline and regression, but it continues to strengthen. What is it all about...
September 20, 2023, 12:10 pm
Seelos tumbles 66% as depression drug fails after it recruits too few patients
Seelos Therapeutics (NASDAQ:SEEL) Inc's share price plummeted by 66% pre-market after the company announced that its phase II study for SLS-002, a tre...
September 20, 2023, 8:33 am
Seelos therapeutics' stock slides 36% after trial of treatment for suicidal ideation has too few patients to meet endpoint
Seelos Therapeutics Inc.'s stock SEEL tumbled 36% in premarket trade Wednesday, after the company reported promising results from a trial of a treatme...
September 20, 2023, 7:46 am
Pfizer's (pfe) alopecia areata drug litfulo receives eu nod
Pfizer (PFE) gets marketing authorization in the EU for Litfulo to treat adults and adolescent patients...
September 19, 2023, 11:18 am
Gsk's hiv-prevention drug apretude approved by european commission
The European Commission (EC) has authorised GSK PLC (LSE:GSK, NYSE:GSK) subsidiary ViiV Healthcare's HIV-prevention drug Apretude. Known scientificall...
September 19, 2023, 7:19 am
Biocryst pharmaceuticals rallies on quebec reimbursement for orladeyo angioedema treatment
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares jumped in early Monday trading after it told investors that the Institut national d'excellence en santé...
September 18, 2023, 10:53 am
Merck (mrk) gets chmp nod for keytruda in adjuvant lung cancer
Merck's (MRK) Keytruda gets a positive CHMP opinion, recommending the approval of the drug for the adjuvant treatment of ...
September 18, 2023, 9:47 am